Quantcast
Treating C Diff Infection With Oral Frozen Encapsulated

Treating C. Diff Infection With Oral, Frozen Encapsulated Fecal Material

Provided by Noah Brown, The JAMA Network Journals A preliminary study has shown the potential of treating recurrent Clostridium difficile infection (a bacterium that is one of the most common causes of infection of the colon) with oral...

Latest Gram positive bacteria Stories

Study Shows Hospitalized Patients Don't Wash Their Hands Enough
2014-10-09 03:57:16

Provided by McMaster University Hospital visitors and staff are greeted with hand sanitizer dispensers in the lobby, by the elevators and outside rooms as reminders to wash their hands to stop infections, but just how clean are patients' hands? A study led by McMaster University researcher Dr. Jocelyn Srigley has found that hospitalized patients wash their hands infrequently. They wash about 30 per cent of the time while in the washroom, 40 per cent during meal times, and only three...

2014-10-09 12:28:58

Results for groundbreaking multi-center study of lead drug candidate RBX2660 (microbiota suspension) presented at IDWeek 2014 PHILADELPHIA, Oct. 9, 2014 /PRNewswire/ -- Rebiotix Inc. announced today that results of the Phase 2 PUNCH(TM) CD Study found that the overall efficacy of RBX2660 in the treatment of recurrent Clostridium difficile infection was 87.1%. The study also found that administration of RBX2660 was well-tolerated and demonstrated satisfactory safety in the 60-day...

2014-10-07 08:29:40

LAUSANNE, Switzerland, October 7, 2014 /PRNewswire/ -- Debiopharm Group(TM)(Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs as well as companion diagnostics, announced today excellent progress of its Phase I single and multiple ascending dose study of Debio 1450, a highly potent anti-infective agent selectively active against Staphylococcus species, including all known resistant strains such as...

2014-09-23 12:29:47

CHICAGO, Sept. 23, 2014 /PRNewswire-USNewswire/ -- C Diff Foundation is proud to present the 2014 "Raising C.difficile Awareness" conference. Join us November 4(th) at 8 a.m. - 5 p.m. at the University of Illinois at Chicago, Student Center, West 828 S. Wolcott Avenue, Thompson Room, Chicago, IL. World renowned topic experts will be presenting data for C. difficile and Hospital-Acquired Infection (HAI) prevention, treatments, and environmental safety. To view the conference details,...

2014-09-11 08:27:38

-- Conference Call Scheduled for Friday, September 12, 2014, at 9:15 a.m. EDT -- ROCKVILLE, Md., Sept. 11, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today that it will host a an investor conference call on Friday, September 12, 2014, at 9:15 a.m. EDT. The conference call will highlight...

2014-09-07 08:20:25

ROCKVILLE, Md., Sept. 7, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and diseases, announced today preclinical data that further validate the Company's novel approach to preventing Clostridium difficile (C. difficile). The U.S. Centers for Disease Control has identified C. difficile as an "urgent public health threat," and it...

2014-09-03 08:32:42

ROCKVILLE, Md., Sept. 3, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today that Jeffrey Riley, CEO, is scheduled to present at the 16(th) Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. Mr. Riley is scheduled to present at 10:25 a.m. (Eastern Time) on Tuesday,...

Research Sniffs Out Smell Of Disease In Feces
2014-09-02 03:10:38

University of Leicester A fast-sensitive "electronic-nose" for sniffing the highly infectious bacteria C. diff, that causes diarrhea, temperature and stomach cramps, has been developed by a team at the University of Leicester. Using a mass spectrometer, the research team has demonstrated that it is possible to identify the unique 'smell' of C. diff which would lead to rapid diagnosis of the condition. What is more, the Leicester team say it could be possible to identify different...

2014-09-02 08:29:18

-- Company Completes Final Preclinical Toxicology Study and Prepares to File Investigational New Drug (IND) in 2H 2014 -- ROCKVILLE, Md., Sept. 2, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today positive results from its final preclinical toxicology study of SYN-004. Per U.S. Food and Drug Administration (FDA)...

2014-08-28 08:27:37

-- Fujifilm's pAVEway(TM) Platform Demonstrated >25-fold Improvement in SYN-004 Expression Titers -- ROCKVILLE, Md., Aug. 28, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, and FUJIFILM Diosynth Biotechnologies UK Limited (Fujifilm), announced today confirmation of exceptional results from the initial phase of cGMP manufacturing of...


Latest Gram positive bacteria Reference Libraries

0_acc42e71b0d88e5b1f3520ddbf139579
2011-04-28 14:45:47

Streptococcus salivarius is a species of spherical, Gram-positive bacteria which colonize the mouth and upper respiratory tract of humans a few hours after birth, making further exposure to the bacteria harmless. The bacterium is an opportunistic pathogen which rarely makes its way into the bloodstream where it is associated with septicemia cases in people with neutropenia. It has different characteristics when exposed to different environmental nutrients. In the lab a SYTA plate is used...

0_1b337eb3ae50456f130e22153cc80436
2011-04-28 14:40:22

Streptococcus pyogenes is a spherical, Gram-positive bacterium is the cause of Group A streptococcal infections. It displays streptococcal group A antigen on its cell wall. When it is cultured on blood agar plates it produces large zones of beta-hemolysis. They are catalase-negative and in ideal conditions it has an incubation period of about 1-3 days. It is an infrequent part of the skin flora. It is the cause of many important human diseases, ranging from mild superficial skin infections...

0_9fb0173be70876d98667eddc1e274866
2011-04-28 14:27:08

Streptococcus pneumoniae, or pneumococcus, is Gram-positive, alpha-hemolytic, bile-soluble aerotolerant, anaerobic member of the genus Streptococcus. It was recognized as a major cause of pneumonia in the late 19th century and is thus the subject of many humoral immunity studies. It causes many other types of pneumococcal infections other than pneumonia including acute sinusitis, otitis media, meningitis, bacteremia, sepsis, septic arthritis, peritonitis, cellulites, and brain abscess. It...

0_097d9a33e1035f1ca4b33243c5beaafa
2011-04-26 23:26:27

Streptococcus oralis is a Gram positive bacterium that grows characteristically in chains. On a Wilkins-Chalgren agar plate it will form slam white colonies. It is classified as a member of the streptococcus mitis group and is found in high numbers in the oral cavity. S. oralis produce neuraminidase and an IgA protease and cannot bind α-amylase.

0_b8b1f3bc239d54bf277f330c7dafdbb1
2011-04-26 23:21:38

Streptococcus mutans is a Gram-positive cocci, Facultative anaerobic bacterium commonly found in the human oral cavity and is a significant contributor to tooth decay. J Kilian Clarke first described the microbe in 1924. The first colonizers of the tooth surface are mainly Neisseria spp. and streptococci, including S. mutans. The pioneer species changes the local environmental conditions through growth and metabolism thus allowing more fastidious organisms to further colonize after them,...

More Articles (14 articles) »
Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related